Paid Clinical Trials in Omaha, NE

Find paid studies that are recruiting healthy participants in Omaha, NE. Filter by distance, duration, and inclusion criteria to find clinical trials that pay well for your time.

Popular Trials

Michael Bask Gill, B Sc

Last Reviewed: February 22nd, 2025

Procedure

AZD9550 + AZD6234 for Obesity

Recruiting0 awardsPhase 2

Omaha, Nebraska

This trial aims to see if giving AZD9550 and AZD6234 together as once weekly injections is better for weight loss in overweight or obese individuals with weight-related health issues, compared to a

Monoclonal Antibodies

Glofitamab + Gemcitabine + Oxaliplatin for Lymphoma

Recruiting1 awardPhase 2

Omaha, Nebraska

"This trial aims to see how often and how severe cytokine release syndrome (CRS) occurs in patients with diffuse large B-cell lymphoma (DLBCL) who are treated with a combination of

Alkylating agents

Cyclophosphamide for Graft-versus-Host Disease

Recruiting1 awardPhase 2

Omaha, Nebraska

This trial will look at how well patients feel after a stem cell transplant when they receive different doses of a medication called cyclophosphamide to prevent complications.

Procedure

Pocenbrodib for Prostate Cancer

Recruiting1 awardPhase 1 & 2

Omaha, Nebraska

This trial is testing different doses of a drug called Pocenbrodib to see if it is safe and effective in treating advanced prostate cancer. The drug will be tested alone or in combination with

Anti-viral

Obeldesivir for RSV

Recruiting0 awardsPhase 2

Omaha, Nebraska

This trial aims to test if a drug called obeldesivir (ODV) is safe and well-tolerated in children with respiratory syncytial virus (RSV) infection. It

Behavioural Intervention

Inclined Exercise for COPD

Recruiting1 award2 criteria

Omaha, Nebraska

This trial aims to find out if walking on an incline during an exercise program is more effective than walking on a flat surface for improving breathing and exercise tolerance in COPD patients undergoing pulmonary rehabilitation.

Popular Filters

Phase 3 Trials

Xanthine Oxidase Inhibitor

AR882 for Gout

Recruiting1 awardPhase 3

Omaha, Nebraska

This trial will test the effects and safety of AR882 on lowering serum uric acid levels in gout patients. They will compare two different doses of AR882 to a placebo over a period of

Monoclonal Antibodies

Ravulizumab for Kidney Transplant

Recruiting1 awardPhase 3

Omaha, Nebraska

"This trial aims to show whether ravulizumab is more effective than a placebo in reducing the need for dialysis after a kidney transplant from a deceased donor in high-risk adult patients."

Monoclonal Antibodies

Sacituzumab Tirumotecan for Ovarian Cancer

Recruiting2 awardsPhase 3

Omaha, Nebraska

This trial aims to see if a new combination of drugs is safe and well-tolerated for people with cancer. It also wants to find out if this new treatment helps people live longer without their cancer

Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonist

Atogepant for Migraine

Recruiting1 awardPhase 3

Papillion, Nebraska

This trial aims to study a new medication called atogepant for preventing chronic migraine in adolescents aged 12 to 17 years. The study will compare the effectiveness of atogepant to a

Phosphodiesterase-4 Inhibitor

Nerandomilast for Interstitial Lung Disease

Recruiting1 awardPhase 3

Omaha, Nebraska

This trial aims to study the effects of a medicine called nerandomilast on the lungs of people with lung fibrosis related to systemic autoimmune rheumatic disease. Participants must be adults with no improvement in

Monoclonal Antibodies

Amivantamab + FOLFIRI for Colorectal Cancer

Recruiting2 awardsPhase 3

Omaha, Nebraska

This trial aims to compare the effectiveness of two different treatment regimens for patients with colorectal cancer that has come back after previous treatment. One group will receive a combination of amivantamab and chemotherapy

Trials With No Placebo

Virus Therapy

mRNA-1083 Vaccine for Influenza and COVID-19

Recruiting1 awardPhase 2

Norfolk, Nebraska

This trial will test a new vaccine that combines flu and COVID-19 protection in adults aged 18 to 65. The study will look at how well the vaccine works, how participants react to it

Behavioural Intervention

Movement Velocity Biofeedback for Sarcopenia

Recruiting1 award1 criteria

Omaha, Nebraska

This trial aims to see if providing cues during resistance training for older adults with sarcopenia can improve their physical performance and motivation. Participants will visit the lab once a week for 3 weeks, perform

Behavioral Intervention

Motivational Interviewing for Cerebral Palsy

Recruiting1 award1 criteria

Boys Town, Nebraska

"This trial will use wearable activity monitors to see if coaching can help increase daily steps in individuals with cerebral palsy who are typically less active."

Monoclonal Antibodies

Sacituzumab Tirumotecan for Ovarian Cancer

Recruiting2 awardsPhase 3

Omaha, Nebraska

This trial aims to see if a new combination of drugs is safe and well-tolerated for people with cancer. It also wants to find out if this new treatment helps people live longer without their cancer

Procedure

MK-8527 + FTC/TDF for Healthy Subjects

Recruiting1 awardPhase 1

Lincoln, Nebraska

This trial aims to understand how the drug MK-8527 behaves in the body of a healthy individual over time. Researchers want to see if there are any differences in how the body processes MK-852

Electrical Stimulation

Electrical Stimulation for Cerebral Palsy

Recruiting1 award6 criteria

Omaha, Nebraska

This trial aims to test if gentle electrical stimulation can help children with cerebral palsy walk better. The stimulation sends small pulses to muscles to help them activate. Researchers will test different ways of using this stimulation

Trials Offering Remuneration

Procedure

MK-8527 + FTC/TDF for Healthy Subjects

Recruiting1 awardPhase 1

Lincoln, Nebraska

This trial aims to understand how the drug MK-8527 behaves in the body of a healthy individual over time. Researchers want to see if there are any differences in how the body processes MK-852

Procedure

INCB000631 for Healthy Adults

Recruiting0 awardsPhase 1

Lincoln, Nebraska

"This trial will test the safety, tolerability, and how the body processes a new drug called INCB000631 when taken by mouth in healthy adults. It will also look at how food affects the

Cancer Vaccine

mRNA Vaccine for Flu

Recruiting0 awardsPhase 1 & 2

Omaha, Nebraska

This trial will test a new pandemic flu vaccine on 276 healthy adults at different dose levels to see which one works best compared to a placebo. Each participant will be in the study for about 13

Procedure

NX-5948 Bioavailability Study in Healthy Subjects

Recruiting1 awardPhase 1

Lincoln, Nebraska

This trial is looking at how well NX-5948 tablets work compared to capsules, and how food and certain medications affect the way NX-5948 is absorbed in the body.

Procedure

TBD11 Safety Study in Healthy Adults

Recruiting0 awardsPhase 1

Lincoln, Nebraska

This trial is testing a new drug called TBD11 on healthy adults. It will be done in two parts. The first part will test different doses of the drug and how it interacts with food, while

Procedure

NX-5948 Study in Healthy Subjects

Recruiting1 awardPhase 1

Lincoln, Nebraska

This trial aims to study how the body processes a new drug called NX-5948. In the first phase, researchers will look at how the drug affects the body and explore potential biomarkers. The

View More Related Trials

CVXGA (CVXGA50)

Investigational varicella vaccine

NNC0662-0419

Subthreshold Vestibular Conditioning

VAX-31

CagriSema

BNT327

Amulet™ 2 Left Atrial Appendage (LAA) Occluder

Lumateperone

LASIK +1 More

Investigational varicella vaccine

Carboplatin +4 More

Beef Consumption

Felzartamab

COVID-19 Vaccine +4 More

Temozolomide +1 More

Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine

Vutrisiran

KT-621

Orforglipron

VXA-CoV2-3.1

Amivantamab +1 More

V350A +1 More

Remternetug

Aquablation Therapy

Sonrotoclax +1 More

Acasunlimab +1 More

mRNA-1273.712

Survodutide

PF-06821497

Suzetrigine

Pembrolizumab +1 More

V540B

Etavopivat

CD388

CRB-601

BHV-2100

GDC-8264

mRNA-1010

MRT-6160

Enlicitide

AZD6234

enVista Aspire EA or Aspire Toric ETA IOLs

NX-5948

mRNA-1403

225Ac-DOTATATE (RYZ101) +1 More

Tirzepatide +1 More

Teen Connection Project (TCP)

Transcutaneous Current Stimulation

Obeldesivir

Preconception Screening Questionnaire

JCXH-105

View more paid studies omaha

See more medical studies focusing on paid studies omaha

Frequently Asked Questions

Do I need insurance to participate in a trial?

Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).

Is there any support for travel costs?

Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.

Will I know what medication I am taking?

This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.

How long do clinical trials last?

Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.

Do you verify all the trials on your website?

All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.

How quickly will I hear back from a clinical trial?

Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.